Cirrhosis typically causes low cholesterol, not high cholesterol. Because the liver is responsible for producing most of the cholesterol in your blood, a scarred and damaged liver loses the ability to make it efficiently. In one study, people with cirrhosis had average total cholesterol of 138 mg/dL compared to 184 mg/dL in a healthy comparison group. The sicker the liver, the lower cholesterol tends to drop.
Why Cirrhosis Lowers Cholesterol
Your liver manufactures roughly 80% of your body’s cholesterol. It also builds the protein carriers (lipoproteins) that shuttle cholesterol and other fats through your bloodstream. As cirrhosis replaces healthy liver tissue with scar tissue, the organ progressively loses the machinery it needs to produce both cholesterol and those carriers. The result is a measurable decline in total cholesterol, LDL (“bad” cholesterol), and HDL (“good” cholesterol).
The liver also converts cholesterol into bile acids, which help you digest fat. In cirrhosis, this conversion process breaks down too. You might expect that failure to clear cholesterol would cause a buildup, but the drop in production is so severe that it overwhelms any reduction in clearance. The net effect is lower blood cholesterol across the board.
Cholesterol Falls as Liver Disease Worsens
Doctors gauge cirrhosis severity using scoring systems like Child-Pugh (classes A, B, and C) and MELD (a numerical score). Research shows that cholesterol levels decline in a nearly linear pattern as these scores rise. In one study comparing cirrhosis patients at different stages, average LDL cholesterol was 80 mg/dL across all cirrhosis patients versus 137 mg/dL in healthy controls. Total cholesterol, LDL, and HDL all followed this downward trend as liver damage progressed.
Triglycerides behave a bit differently. They don’t drop as predictably with worsening cirrhosis. In alcoholic cirrhosis specifically, triglycerides can actually be slightly elevated in moderate disease (Child-Pugh B) before falling again in the most advanced stage, when the liver can no longer assemble fat molecules at all. In non-alcoholic cirrhosis, triglycerides tend to run lower than normal from the start.
When Low Cholesterol Becomes a Warning Sign
In people without liver disease, low cholesterol is generally considered favorable. In cirrhosis, it signals something very different: a liver that is failing. Extremely low HDL cholesterol, in particular, carries prognostic weight. Research has identified an HDL level below about 16 mg/dL as an independent risk factor for death within 180 days in patients with decompensated cirrhosis. At that level, the liver has lost so much function that it can barely produce the lipoproteins needed to keep cholesterol circulating.
A sudden or significant drop in cholesterol on routine blood work can prompt doctors to look more closely at liver function, especially if other markers like bilirubin and albumin are also moving in the wrong direction.
The Exception: Biliary Cirrhosis
There is one important exception where cirrhosis can raise cholesterol. Primary biliary cholangitis (PBC), an autoimmune condition that damages the bile ducts inside the liver, often causes elevated LDL cholesterol. The mechanism is complex. When bile ducts are destroyed, bile acids back up into the bloodstream, and the liver produces an unusual particle called lipoprotein X that registers as LDL on standard blood tests. This can make cholesterol numbers look alarmingly high even though the cardiovascular risk picture is more nuanced than it appears.
PBC also reduces the activity of a liver enzyme that helps mature HDL cholesterol, leading to lower HDL levels. So the lipid profile in biliary cirrhosis can look paradoxical: high LDL alongside low HDL. If you’ve been told you have both cirrhosis and high cholesterol, PBC or another biliary condition may be the underlying cause.
Managing Cholesterol With Cirrhosis
For people with mild, well-compensated cirrhosis (Child-Pugh A) who also have cardiovascular risk factors like diabetes or a history of heart disease, cholesterol-lowering medications can still be appropriate. Experts recommend more frequent liver enzyme monitoring, particularly in the first month and then every three to six months, but the medications are not automatically off the table just because cirrhosis is present.
The picture changes with more advanced disease. For patients with moderate to severe cirrhosis (Child-Pugh B or C), cholesterol-lowering medications carry a higher risk of muscle and liver toxicity. Patients with bilirubin levels above 3 mg/dL appear to be at particular risk for serious muscle breakdown. In practice, many hepatologists will discontinue these medications once cirrhosis reaches that stage, partly because cholesterol levels are typically already low and partly because the risk no longer justifies the benefit.
If your cholesterol has dropped noticeably and you have known liver disease, that change likely reflects your liver’s declining synthetic capacity rather than an improvement in cardiovascular risk. It’s one of the reasons standard cholesterol targets don’t apply in the same way to people with cirrhosis.